loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

Approved Drug Products containing 206651 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 BELCHER (3)

filter

01 CAPSULE;ORAL (3)

filter

01 RX (3)

filter

01 TACROLIMUS (3)

filter

01 No (3)

URL Supplier Web Content
CAPSULE; ORAL
EQ 5MG BASE
2017-11-30
206651
TACROLIMUS
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE; ORAL
EQ 0.5MG BASE
2017-11-30
206651
TACROLIMUS
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE; ORAL
EQ 1MG BASE
2017-11-30
206651
TACROLIMUS
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 206651

Looking for FDA Orange Book APPLICATION 206651 3

19

Belcher Pharmaceuticals, LLC, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is TACROLIMUS, with a corresponding application number 206651.

Regulatory Information RX

With a dosage strength EQ 5MG BASE

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug No

Approved since 2017-11-30

Therapeutic Equivalence (TE) Code AB

18

Belcher Pharmaceuticals, LLC, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is TACROLIMUS, with a corresponding application number 206651.

Regulatory Information RX

With a dosage strength EQ 0.5MG BASE

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug No

Approved since 2017-11-30

Therapeutic Equivalence (TE) Code AB

17

Belcher Pharmaceuticals, LLC, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is TACROLIMUS, with a corresponding application number 206651.

Regulatory Information RX

With a dosage strength EQ 1MG BASE

Dosage Form Route CAPSULE; ORAL

Reference Listed Drug No

Approved since 2017-11-30

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY